VR Logo

Laurus Labs Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

42 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 2005

Chairman: Malempati Venugopala Rao

Managing Director: --

Group: --

Listing: NSE: LAURUSLABS, BSE: 540222

Headquarters: Vishakhapatnam, Andhra Pradesh

Website: www.lauruslabs.com

Key Facts

Market cap: R 23,693.68 Cr

Revenue (TTM): R 4,240.72 Cr

Earnings (TTM): R 797.05 Cr

Cash: R 1.74 Cr

Total Debt: R 1,056.88 Cr

Promoters' ownership: 27.45%

Liquidity: High

52 Week range: R 80.20 - 452.30

Face value: R2.00

Shares outstanding: 53,66,02,385

9 Years Aggregate:

  • CFO: 1,685.08 Cr
  • EBITDA: 2,716.60 Cr
  • Net Profit: 1,117.25 Cr

Stock Performance

Time Period Laurus Labs S&P BSE Healthcare S&P BSE Mid Cap
YTD26.436.1112.35
1 month23.688.99-1.72
3 months20.664.416.63
1 Year459.0353.4474.10
3 Years64.4618.476.39
5 Years--8.2113.02
10 Years--14.1010.82
As on 16-Apr-2021
Year Laurus Labs S&P BSE Mid Cap S&P BSE Healthcare
2020379.5019.8761.45
2019-6.06-3.05-3.55
2018-29.95-13.31-5.89
201712.9048.130.49

Review & Analysis